Clinical Trial Update: Study to Evaluate Induction of HBV Virus Neutralizing Antibodies Using VVX001 [Phase 2]

View source ↗

Summary

Phase 2 study evaluating induction of hepatitis B virus neutralizing antibodies with VVX001 is in progress with status not yet determined.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• VVX001

Snippet

Sponsor: Viravaxx AG | Conditions: Hepatitis B | Phase 2 | Status: UNKNOWN